Protocol of the LATFIA trial (Laser Assisted Treatment of Fistula in Ano): a multicentre, prospective, randomized controlled trial comparing fistula‐tract laser closure (FiLaC™) with rectal advancement flap for high trans‐sphincteric fistulas
Authors:
- Marie GaillardMGMarie Gaillard
- Sylvie Van Den BroeckSBSylvie Van Den Broeck
- Bart Op de BeeckBBBart Op de Beeck
- Kristien WoutersKWKristien Wouters
- Jasper StijnsJSJasper Stijns
- Dirk Van de PutteDPDirk Van de Putte
- Ben GysBGBen Gys
- Bert HoubenBHBert Houben
- Els Van DesselEDEls Van Dessel
- Gabriele BislenghiGBGabriele Bislenghi
- Niels KomenNKNiels Komen
- 18 March 2024
- journal article
- research article
- Published by Wiley in Colorectal Disease
- Vol. 26 (5) , 1038-1046
Abstract
Aim: Anal fistula is one of the most common anal diseases, affecting between 1 and 3 per 10 000 people per year. Symptoms have a potentially severe effect on a patient's quality of life. Surgery is the mainstay of treatment, aiming to cure the fistula and preserve anal sphincter function. Rectal advancement flap (RAF) is currently the gold standard treatment but has recurrence rates varying between 20% and 50% and might lead to disturbance of continence. The aim of the trial described in this work is to discover if the minimally invasive fistula tract laser closure (FiLaC (TM)) technique could achieve higher healing rates and a better functional outcome than RAF. Method: We will perform a randomized prospective multicentre noninferiority study of the treatment of high trans-sphincteric perianal fistulas, comparing FiLaC (TM) with RAF in terms of fistula healing, recurrence rate, functional outcome and quality of life. Primary and secondary fistula healing will be evaluated at 26 and 52 weeks' follow-up. Quality of life will be evaluated using the SF-36 questionnaire, the Faecal Incontinence Quality of Life Scale questionnaire and the Vaizey score at 3, 6, 12 and 26 weeks postoperatively. Conclusion: High trans-sphincteric fistulas have a potentially severe effect on a patient's quality of life. Classical treatment with RAF is a time-consuming invasive procedure. The LATFIA trial aims to compare FiLaC (TM) with the gold standard treatment with RAF. In case of noninferiority, FiLaC (TM) treatment could be standardized as a first line treatment for high trans-sphincteric fistulas. Better conservation of the patient's anal sphincter function could possibly be obtained. Likewise, we will report on the postoperative quality of life when applying these two techniques.Keywords
Funding Information
- Fonds Wetenschappelijk Onderzoek
This publication has 19 references indexed in Scilit:
- AFCOS: The Development of a Cryptoglandular Anal Fistula Core Outcome SetAnnals of Surgery, 2022
- Closing Perianal Fistulas Using a Laser: Long-Term Results in 103 PatientsDiseases of the Colon & Rectum, 2018
- Randomized clinical trial comparing collagen plug and advancement flap for trans-sphincteric anal fistulaBritish Journal of Surgery, 2017
- Rectal advancement flap for the treatment of complex cryptoglandular anal fistulas: a systematic review and meta-analysisInternational Journal of Colorectal Disease, 2017
- Long-term Follow-up After Surgery for Simple and Complex Cryptoglandular FistulasDiseases of the Colon & Rectum, 2015
- Systematic review and meta-analysis of surgical interventions for high cryptoglandular perianal fistulaInternational Journal of Colorectal Disease, 2014
- A Diagnostic Accuracy Meta-analysis of Endoanal Ultrasound and MRI for Perianal Fistula AssessmentDiseases of the Colon & Rectum, 2012
- Surgical intervention for anorectal fistulaCochrane Database of Systematic Reviews, 2010
- Impact of two different types of anal retractor on fecal continence after fistula repairDiseases of the Colon & Rectum, 2003
- Anal fistulas at St Mark's HospitalBritish Journal of Surgery, 1977